Literature DB >> 29305274

Combination of 24-Hour and 7-Day Relative Neurological Improvement Strongly Predicts 90-Day Functional Outcome of Endovascular Stroke Therapy.

Jie Pu1, Huaiming Wang2, Mingyi Tu3, Wenjie Zi4, Yonggang Hao5, Dong Yang4, Wenhua Liu6, Yue Wan7, Yu Geng8, Min Lin9, Ping Jin10, Yunyun Xiong4, Gelin Xu4, Qin Yin11, Xinfeng Liu12.   

Abstract

BACKGROUND AND
PURPOSE: Early judgment of long-term prognosis is the key to making medical decisions in acute anterior circulation large-vessel occlusion stroke (LVOS) after endovascular treatment (EVT). We aimed to investigate the relationship between the combination of 24-hour and 7-day relative neurological improvement (RNI) and 90-day functional outcome.
METHODS: We selected the target population from a multicenter ischemic stroke registry. The National Institutes of Health Stroke Scale (NIHSS) scores at baseline, 24 hours, and 7 days were collected. RNI was calculated by the following equation: (baseline NIHSS - 24-hour/7-day NIHSS)/baseline NIHSS × 100%. A modified Rankin Scale score of 0-2 at 90 days was defined as a favorable outcome. Multivariable logistic regression analysis was used to evaluate the relationship between RNI and 90-day outcome. Receiver operator characteristic curve analysis was performed to identify the predictive power and cutoff point of RNI for functional outcome.
FINDINGS: A total of 568 patients were enrolled. Both 24-hour and 7-day RNI were independent predictors of 90-day outcome. The best cutoff points of 24-hour and 7-day RNI were 28% and 42%, respectively. Compared with those with 24-hour RNI of less than 28% and 7-day RNI of less than 42%, patients with 24-hour RNI of 28% or greater and 7-day RNI of 42% or greater had a 39.595-fold (95% confidence interval 22.388-70.026) increased probability of achieving 90-day favorable outcome.
CONCLUSIONS: The combination of 24-hour and 7-day RNI very strongly predicts 90-day functional outcome in patients with acute anterior circulation LVOS who received EVT, and it can be used as an early accurate surrogate of long-term outcome.
Copyright © 2018 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Stroke; endovascular treatment; outcome; relative neurological improvement

Mesh:

Year:  2018        PMID: 29305274     DOI: 10.1016/j.jstrokecerebrovasdis.2017.11.042

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  5 in total

1.  Delayed neurological improvement is predictive to long-term clinical outcome on endovascular thrombectomy patients.

Authors:  Haodi Cai; Yunfei Han; Wen Sun; Mingming Zha; Xuan Shi; Kangmo Huang; Qingwen Yang; Xiaoke Wang; Rui Liu; Xinfeng Liu
Journal:  Interv Neuroradiol       Date:  2021-09-13       Impact factor: 1.764

2.  Xingnao Kaiqiao Acupuncture Method Combined with Temporal Three-Needle in the Treatment of Acute Ischemic Stroke: A Randomized Controlled Trial.

Authors:  Zhongtao Song; Qingyuan Huang; Yuxia Guo; Xiaodong Song; Xuan Zhang; Huajun Xiao
Journal:  Comput Intell Neurosci       Date:  2022-06-29

Review 3.  Acute ischemic stroke patients with diffusion-weighted imaging-Alberta Stroke Program Early Computed Tomography Score ≤ 5 can benefit from endovascular treatment: a single-center experience and literature review.

Authors:  Kangping Song; Min Guan; Wenxian Li; Zhen Jing; Xiaomei Xie; Changzheng Shi; Jianye Liang; Hongyu Qiao; Li'an Huang
Journal:  Neuroradiology       Date:  2019-02-06       Impact factor: 2.804

4.  Influence Factors and Predictive Models for the Outcome of Patients with Ischemic Stroke after Intravenous Thrombolysis: A Multicenter Retrospective Cohort Study.

Authors:  Jin Hu; Zhixian Fang; Xia Lu; Fei Wang; Ningyuan Zhang; Wenliang Pan; Xinzheng Fu; Gongchun Huang; Xiaoli Tan; Wenyu Chen
Journal:  Oxid Med Cell Longev       Date:  2022-08-17       Impact factor: 7.310

5.  National Institutes of Health Stroke Scale: An Alternative Primary Outcome Measure for Trials of Acute Treatment for Ischemic Stroke.

Authors:  Vicky Chalos; Nadinda A M van der Ende; Hester F Lingsma; Maxim J H L Mulder; Esmee Venema; Simone A Dijkland; Olvert A Berkhemer; Albert J Yoo; Joseph P Broderick; Yuko Y Palesch; Sharon D Yeatts; Yvo B W E M Roos; Robert J van Oostenbrugge; Wim H van Zwam; Charles B L M Majoie; Aad van der Lugt; Bob Roozenbeek; Diederik W J Dippel
Journal:  Stroke       Date:  2019-12-04       Impact factor: 7.914

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.